Using market-exclusivity incentives to promote pharmaceutical innovation.
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA. akesselheim@partners.org
Aaron S
AS
Kesselheim
D035843:Biomedical Research / Q000266:history / Q000331:legislation & jurisprudence; D055808:Drug Discovery / Q000266:history* / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000266:history* / Q000331:legislation & jurisprudence; D049673:History, 20th Century; D007880:Legislation, Drug / Q000266:history*; D010330:Patents as Topic / Q000266:history* / Q000331:legislation & jurisprudence; D055553:Prescription Drugs / Q000266:history; D011640:Public Policy / Q000266:history; D014481:United States
D055553:Prescription Drugs